120 related articles for article (PubMed ID: 24235082)
1. The inflammation-lipocalin 2 axis may contribute to the development of chronic kidney disease.
Hashikata A; Yamashita A; Suzuki S; Nagayasu S; Shinjo T; Taniguchi A; Fukushima M; Nakai Y; Nin K; Watanabe N; Asano T; Abiko Y; Kushiyama A; Nagasaka S; Nishimura F
Nephrol Dial Transplant; 2014 Mar; 29(3):611-8. PubMed ID: 24235082
[TBL] [Abstract][Full Text] [Related]
2. Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease.
Nakagawa S; Nishihara K; Miyata H; Shinke H; Tomita E; Kajiwara M; Matsubara T; Iehara N; Igarashi Y; Yamada H; Fukatsu A; Yanagita M; Matsubara K; Masuda S
PLoS One; 2015; 10(8):e0136994. PubMed ID: 26317775
[TBL] [Abstract][Full Text] [Related]
3. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.
Viau A; El Karoui K; Laouari D; Burtin M; Nguyen C; Mori K; Pillebout E; Berger T; Mak TW; Knebelmann B; Friedlander G; Barasch J; Terzi F
J Clin Invest; 2010 Nov; 120(11):4065-76. PubMed ID: 20921623
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition.
Ko GJ; Grigoryev DN; Linfert D; Jang HR; Watkins T; Cheadle C; Racusen L; Rabb H
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1472-83. PubMed ID: 20181666
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease.
Naudé PJ; Nyakas C; Eiden LE; Ait-Ali D; van der Heide R; Engelborghs S; Luiten PG; De Deyn PP; den Boer JA; Eisel UL
FASEB J; 2012 Jul; 26(7):2811-23. PubMed ID: 22441986
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation.
Malyszko J; Malyszko JS; Koc-Zorawska E; Kozminski P; Mysliwiec M
Kidney Blood Press Res; 2009; 32(6):464-9. PubMed ID: 20068352
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury.
Devarajan P
Nephrol Dial Transplant; 2008 Dec; 23(12):3737-43. PubMed ID: 18809975
[No Abstract] [Full Text] [Related]
9. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin 2 regulation and its complex role in inflammation and cancer.
Li C; Chan YR
Cytokine; 2011 Nov; 56(2):435-41. PubMed ID: 21855366
[TBL] [Abstract][Full Text] [Related]
11. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure.
Yndestad A; Landrø L; Ueland T; Dahl CP; Flo TH; Vinge LE; Espevik T; Frøland SS; Husberg C; Christensen G; Dickstein K; Kjekshus J; Øie E; Gullestad L; Aukrust P
Eur Heart J; 2009 May; 30(10):1229-36. PubMed ID: 19329498
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
[TBL] [Abstract][Full Text] [Related]
13. Genomics and biological activity of neutrophil gelatinase-associated lipocalin in several clinical settings.
Virzì GM; Clementi A; de Cal M; Cruz DN; Ronco C
Blood Purif; 2013; 35(1-3):139-43. PubMed ID: 23343559
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin 2 Upregulation Protects Hepatocytes from IL1-β-Induced Stress.
Hu Y; Xue J; Yang Y; Zhou X; Qin C; Zheng M; Zhu H; Liu Y; Liu W; Lou G; Wang J; Wu S; Chen Z; Chen F
Cell Physiol Biochem; 2015; 36(2):753-62. PubMed ID: 26021263
[TBL] [Abstract][Full Text] [Related]
15. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-2 is associated with radioresistance in oral cancer and lung cancer cells.
Shiiba M; Saito K; Fushimi K; Ishigami T; Shinozuka K; Nakashima D; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Takiguchi Y; Tanzawa H
Int J Oncol; 2013 Apr; 42(4):1197-204. PubMed ID: 23403985
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease.
Oberoi R; Bogalle EP; Matthes LA; Schuett H; Koch AK; Grote K; Schieffer B; Schuett J; Luchtefeld M
PLoS One; 2015; 10(9):e0137924. PubMed ID: 26367277
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
Bolignano D; Lacquaniti A; Coppolino G; Campo S; Arena A; Buemi M
Kidney Blood Press Res; 2008; 31(4):255-8. PubMed ID: 18600028
[TBL] [Abstract][Full Text] [Related]
20. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
